Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. human health impact
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Human Health Impact Articles & Analysis

28 news found

Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant

Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant

Creative Enzymes will continue its noble pursuit of exploring the enigmatic world of enzymes, contributing to meaningful scientific discoveries and advancements that will bring about positive impacts on human health and our economy. About Creative EnzymesCreative Enzymes stands as a leading provider of enzyme-related services and solutions. ...

ByCreative Enzymes


Eagle Genomics Appoints Tarun Rishi as New VP Engineering to Further Scale Platform Capabilities

Eagle Genomics Appoints Tarun Rishi as New VP Engineering to Further Scale Platform Capabilities

In the role, Tarun will continue to drive excellence in Eagle Genomics’ technology to deliver the capabilities of its AI-augmented knowledge discovery platform, e[datascientist]™, at scale. e[datascientist]™ uses network science to understand the microbiome in such complex ecosystems that exist within soils, plants, animals and humans, including how they ...

ByEagle Genomics


Vaxxinity to Participate at the Bank of America Securities 2022 Healthcare Conference

Vaxxinity to Participate at the Bank of America Securities 2022 Healthcare Conference

Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human ...

ByVaxxinit


Vaxxinity Receives FDA Fast Track Designation for UB-311 for Treatment of Alzheimer’s Disease

Vaxxinity Receives FDA Fast Track Designation for UB-311 for Treatment of Alzheimer’s Disease

Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human ...

ByVaxxinit


Vaxxinity to Participate at the Jefferies Healthcare Conference

Vaxxinity to Participate at the Jefferies Healthcare Conference

Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human ...

ByVaxxinit


Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment

Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment

The epidemic caused by the Novel Coronavirus has had a significant impact on human health and economic development and has brought severe challenges to global public health security. ...

ByInsilico Medicine


Pronalyse Unveils Therapeutic Enzyme Characterization Service for Your Drug Development

Pronalyse Unveils Therapeutic Enzyme Characterization Service for Your Drug Development

Because enzymes have such a significant impact on human health, research on enzyme-based drugs has emerged as a focus in recent times. ...

ByCreative Proteomics


Vaxxinity Completes Enrollment in Part B of UB-312 Phase 1 Clinical Trial for Parkinson’s Disease

Vaxxinity Completes Enrollment in Part B of UB-312 Phase 1 Clinical Trial for Parkinson’s Disease

¹ The Phase 1 clinical trial is a first-in-human, randomized, double-blinded, placebo-controlled study evaluating the potential of UB-312 in PD. ...

ByVaxxinit


Creative Proteomics: GutFlora Omics Platform Launches Virome Sequencing Service to Investigate Gut Microbiota

Creative Proteomics: GutFlora Omics Platform Launches Virome Sequencing Service to Investigate Gut Microbiota

At present, most of the research on gut microbes focuses on the study of bacteria, and with the deepening of research, the number and types of enteroviruses and their impact on human health and disease have received more and more attention. ...

ByCreative Proteomics


Evox Therapeutics Expands Its Exosome Patent Portfolio

Evox Therapeutics Expands Its Exosome Patent Portfolio

Backed by leading life sciences venture capital groups and supported by a comprehensive intellectual property portfolio, Evox’s mission is to positively impact human health by creating novel exosome-based therapeutics for the treatment of various severe diseases with limited options for patients and their families. ...

ByEvox Therapeutics Limited


Icecure Medical enters into an exclusive agreement in Poland for distribution of the Prosense Cryoablation System

Icecure Medical enters into an exclusive agreement in Poland for distribution of the Prosense Cryoablation System

Mobile SCANMED’s goal is to educate the public about the protection of their health. They want to raise people’s awareness of the need for preventive examinations. They emphasize the importance of taking care of the surroundings and the environment, which have a significant impact on human ...

ByIceCure Medical Ltd


Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS)

Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS)

It is truly a researcher’s dream to be able to witness early ideas and years of discovery at the bench bring us this close to making an impact on human health and disease. My laboratory is ready and eager to embark on this new stage of investigation with KLS-13019 into its therapeutic potential as an anti-neuropathic agent,” said Sara ...

ByNeuropathix, Inc.


Enterome announces first patient dosed in a Phase 1/2 trial with second OncoMimicsTM vaccine, EO2463, in non-Hodgkin lymphoma

Enterome announces first patient dosed in a Phase 1/2 trial with second OncoMimicsTM vaccine, EO2463, in non-Hodgkin lymphoma

EO2463 is an innovative, off-the-shelf microbiome-peptide based cancer vaccine • EO2463 combines four microbiome-peptides of B lymphocytes-specific lineage markers designed to induce the full depletion of malignant B lymphocytes ENTEROME SA, a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to de-code molecular interactions in the gut ...

ByEnterome


SAB to Discuss COVID-19 Review Panel’s Draft Report

SAB to Discuss COVID-19 Review Panel’s Draft Report

The draft report, SAB Technical Review of EPA’s Identification of Research Needs to Address the Environmental and Human Health Impacts of COVID-19, was funded by the 2020 Coronavirus Aid, Relief, and Economic Security (CARES) Act. This research was conducted to assist EPA in its understanding of the environmental and human ...

ByBergeson & Campbell, P.C.


SAB to Review EPA Research on Large Scale Disinfection of COVID-19 Virus

SAB to Review EPA Research on Large Scale Disinfection of COVID-19 Virus

This research is intended to help EPA understand and mitigate the environmental and human health impacts from COVID-19, and identifies EPA research that is already underway as well as new EPA research that has been proposed. ...

ByBergeson & Campbell, P.C.


Agilent Technologies Sponsors Duquesne University Symposium on Exposomics, Toxicity Pathways in Human Health

Agilent Technologies Sponsors Duquesne University Symposium on Exposomics, Toxicity Pathways in Human Health

A panel of scientists from Duquesne University, The Children's Institute of Pittsburgh and The Heinz Endowments will discuss analytical strategies for measuring how environmental exposure impacts human health and chronic disease. The half-day event, "Regional Perspectives to Integrate Exposure and Exposome Measurement with Effects on ...

ByAgilent Technologies, Inc.


EPA’s FY 2013 budget proposal focuses on core environmental and human health protections

The EPA also will release an Interim Report on the Impacts of Hydraulic Fracturing on Drinking Water Resources in 2012. ...

ByUS EPA - Environmental Protection Agency


Streptococcus pneumoniae Exposed in New Online Video

Streptococcus pneumoniae Exposed in New Online Video

Today, the IAQ Video Network and Cochrane & Associates announced the release of another online video to help educate the public about issues that may impact their health. The latest educational video discusses Streptococcus pneumoniae infections and how they may impact human health. ...

ByCochrane & Associates, LLC


Premier Healthcare Alliance Endorses Standardized Environmentally Preferable Products and Services Tool

The Greening the Supply Chain Initiative brings together leaders in all sectors of healthcare to initiate dialogue on ways to create products with reduced environmental and human health impacts. It provides a common set of tools and resources for purchasers, suppliers and manufacturers to help drive a sector-wide ...

ByPractice Greenhealth


Norovirus Outbreaks Impact Both Human Health and Businesses

Norovirus Outbreaks Impact Both Human Health and Businesses

The cruise line responded with additional sanitation and health staff to help bring the outbreak under control and to prevent additional outbreaks. ...

ByCochrane & Associates, LLC

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT